Background And Objective: The radial artery has become a routinely used conduit for coronary artery bypass graft surgery (CABG). Prior to surgery the Allen test is performed to test the patency of the ulnar artery. A positive Allen test, reperfusion >5 seconds, suggests an insufficient perfusion of the hand by the ulnar artery. In this study we investigated if laser speckle contrast analysis (LASCA) provides an objective determination of the reperfusion time.
Materials And Methods: When the hand is illuminated with coherent laser light, the backscattered light will result in an interference pattern consisting of bright and dark areas called speckles. This speckle pattern will change due to movement of red blood cells. LASCA uses these changes to visualize the perfusion during the Allen test. Reperfusion is measured on the palmar side of the hand. The reperfusion time is defined as the time from onset of reperfusion to maximum perfusion calculated by a polynomial curve fit. The reperfusion time of the hand of patients undergoing CABG (n = 30) is measured using LASCA and is compared to the conventional Allen test performed by the nurse practitioner.
Results: LASCA measurements showed a negative Allen test of both hands of 16 patients. Fourteen had a borderline reperfusion time of 5-6 seconds and/or a positive Allen test of one or both hands. No statistical significant difference was observed for the LASCA Allen test compared to the conventional Allen test, P = 0.549 for the left hand and P = 0.223 for the right hand.
Conclusion: LASCA is able to visualize perfusion of the hand and measure a quick, moderate, slow reperfusion response or no reperfusion. It is technically feasible to determine the reperfusion time of the hand. LASCA can be a useful and objective tool to assess ulnar collateral blood supply to the hand prior to harvesting of the radial artery as a bypass graft.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/lsm.22213 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Basic Science and Pathogenesis.
Alzheimers Dement
December 2024
Allen Institute for Brain Science, Seattle, WA, USA.
Background: Alzheimer's Disease is marked by the gradual aggregation of pathological proteins, Tau and beta-amyloid, throughout various areas of the brain. The progression of these pathologies follows a consistent pattern, impacting various cellular populations as it advances through each brain region. Previously, we used Bayesian algorithms to create a continuous progression score to mathematically capture the collective aggregation of multiple pathological variables within a specific brain region.
View Article and Find Full Text PDFBackground: Alzheimer's disease (AD) is neuropathologically characterized by amyloid-β (Aβ) plaques and tau neurofibrillary tangles often quantified by Thal phase and Braak stage, respectively. Aβ also frequently deposits in the cerebrovasculature with severity categorized by a cerebral amyloid angiopathy (CAA) score. These and related measures often show high variability within AD suggesting distinct underlying mechanisms.
View Article and Find Full Text PDFDevelopment of a reference standard to assign bacterial versus viral infection etiology using an all-inclusive methodology for comparison of novel diagnostic tool performance.
Clin Infect Dis
January 2025
MeMed, Tirat Carmel, Israel.
Background: Diagnostic test evaluation requires a reference standard. We describe an approach for creating a reference standard for acute infection using unrestricted adjudication and apply it to compare biomarker tools.
Methods: Adults and children with suspected acute infection enrolled in three prospective studies at emergency departments and urgent cares were included.
Clinical Manifestations.
Alzheimers Dement
December 2024
Department of Neurology, Harvard Medical School, Boston, MA, USA.
Background: Cognitive tests of naming ability have been shown to have diagnostic and prognostic utility in both mild cognitive impairment (MCI) and Alzheimer's disease (AD; Taler & Phillips, 2008). The Boston Naming Test (BNT) is the most common naming test, which consists of 60 black-and-white drawings and takes 20-30 minutes to administer. Retrospective analysis has shown that administering the BNT in an adaptive fashion could result in a comparable measure of the patient's naming ability in only 8 items instead of 60.
View Article and Find Full Text PDFClinical Manifestations.
Alzheimers Dement
December 2024
Memory and Aging Center, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Background: Nearly half the world's population is bi- or multilingual, where diverse interpretations of bilingualism with varying associated sociodemographic factors may lead to inconsistent conclusions in bilingualism and cognitive research and thus our study aimed to further examine this.
Method: We examined the sociodemographic features and bilingualism phenotypes among monolingual and bilingual individuals across three cohorts: Chinese American (CA) from UCSF Memory and Aging Center (n = 517), Mexican American (MA) from HABS-HD project (n = 1,166), and Indians (ID) from National Institute of Mental Health and Neuroscience (NIMHANS) (n = 1,233), encompassing individuals with normal cognition, mild cognitive impairment (MCI), and Alzheimer's dementia (AD). We compared group differences between monolinguals and bilinguals via Student's t-test for continuous variables and with Pearson's Chi-squared test for categorical variables.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!